Evidence map›Paper›PMID 28849105›Full record

ArticleMolecular medicine reports2017

Analysis of gene expression profiling variations induced by hsa‑miR‑145‑5p‑overexpression in laryngeal squamous cell carcinoma cell line Tu‑177.

Yongxia Ding, Yongyan Wu, Wei Gao, Chunming Zhang, Qinli Zhao, Huina Guo, Xukuan Qu, Shuxin Wen, Binquan Wang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yongxia DingNursing College of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Yongyan WuShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Wei GaoShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Chunming ZhangShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Qinli ZhaoShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Huina GuoShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Xukuan QuShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Shuxin WenShanxi Key Laboratory of Otolaryngology, Head and Neck Cancer, Taiyuan, Shanxi 030001, P.R. China.
Binquan WangNursing College of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Shanxi Provincial Cancer Hospital · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the variations of the gene network and biological functions induced by hsa‑miR‑145‑5p in the laryngeal squamous cell carcinoma (LSCC) cell line Tu‑177. A hsa‑miR‑145‑5p‑overexpressed Tu‑177 cell model was established, and the gene expression microarray data of miR‑145‑5p‑overexpressed cells and negative control (NC) cells were analyzed. The differentially expressed genes (DEGs) between two groups were identified, and their potential functions were predicted by functional enrichment analysis. Furthermore, the targets of miR‑145‑5p were identified from the DEGs, and their potential functions and protein‑protein interactions (PPIs) were analyzed. The mRNA expressions of acetyl‑CoA carboxylase β (ACACB), fibroblast growth factor receptor 1 (FGFR1), protein phosphatase 3 catalytic subunit a (PPP3CA) and spleen associated tyrosine kinase (SYK), were analyzed via quantitative polymerase chain reaction. A total of 1,501 upregulated and 887 downregulated genes were identified in the hsa‑miR‑145‑5p‑overexpressed Tu‑177 cells, compared with the NC cells. Of these DEGs, 164 upregulated and 221 downregulated genes were predicted to be targeted by hsa‑miR‑145‑5p. The upregulated target genes were primarily associated with functions of immunity, whereas the downregulated target genes were significantly enriched in the p53 signaling pathway. In the PPI network consisting of 267 target genes, the upregulated ACACB had the greatest degree and interacted with downregulated genes including PPP3CA and SYK, in addition to upregulated genes, including FGFR1. The mRNA expressions of ACACB and FGFR1were markedly enhanced in miR‑145‑5p‑overexpressed Tu‑177 cells, whereas overexpressing miR‑145‑5p significantly reduced mRNA expression of PPP3CA and SYK. hsa‑miR‑145‑5p may exhibit an anticancer role in LSCC via regulating multiple cell processes, including cell proliferation and invasion, fatty acid metabolism, immunity and p53 signaling pathway. These findings provide novel information for the future investigation of miR‑145‑5p functions in LSCC.

Indexed as

Carcinoma, Squamous CellCell Line, TumorComputational BiologyGene Expression Regulation, NeoplasticHumansLaryngeal NeoplasmsMicroarray AnalysisMicroRNAsProtein Interaction MapsSignal TransductionMicroRNAsMIRN145 microRNA, human

Identifiers

PMID28849105
PMCPMC5865762
OpenAlexW2747511050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.